Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (183)
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
861
Price
$53.50
Total Value
$46.07K
Shares Held After
158,930
% of Holdings
0.5%
Vaxcyte, Inc. (PCVX)
GUGGENHIME ANDREW — PRESIDENT AND CFO
Shares
3,044
Price
$54.18
Total Value
$164.92K
Shares Held After
105,176
% of Holdings
2.8%
Vaxcyte, Inc. (PCVX)
GUGGENHIME ANDREW — PRESIDENT AND CFO
Shares
6,956
Price
$53.76
Total Value
$373.96K
Shares Held After
108,220
% of Holdings
6.0%
Camp4 Therapeutics Corp (CAMP)
Mandel-Brehm Josh — Director
Shares
6,551
Price
$1.65
Total Value
$10.81K
Shares Held After
284,968
% of Holdings
2.3%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance&Operations
Shares
275
Price
$1.98
Total Value
$543.68
Shares Held After
504,819
% of Holdings
0.1%
Cocrystal Pharma, Inc. (COCP)
FROST PHILLIP MD ET AL — Director
Shares
75,000
Price
$0.94
Total Value
$70.59K
Shares Held After
1,983,551
% of Holdings
3.8%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
1,604
Price
$27.09
Total Value
$43.44K
Shares Held After
255,263
% of Holdings
0.6%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
30,304
Price
$26.71
Total Value
$809.54K
Shares Held After
256,867
% of Holdings
10.6%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
154
Price
$27.09
Total Value
$4.17K
Shares Held After
20,744
% of Holdings
0.7%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
2,439
Price
$26.71
Total Value
$65.16K
Shares Held After
20,898
% of Holdings
10.5%
Editas Medicine, Inc. (EDIT)
Parison Amy — SVP, Chief Financial Officer
Shares
678
Price
$2.58
Total Value
$1.75K
Shares Held After
14,292
% of Holdings
4.5%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
6,000
Price
$252.98
Total Value
$1.52M
Shares Held After
360,682
% of Holdings
1.6%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
1,269
Price
$29.45
Total Value
$37.38K
Shares Held After
20,422
% of Holdings
5.9%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
5,907
Price
$28.95
Total Value
$171.01K
Shares Held After
21,691
% of Holdings
21.4%
Tiziana Life Sciences Ltd (TLSA)
Elrifi Ivor — Chief Executive Officer
Shares
667,000
Price
$1.00
Total Value
$667.00K
Shares Held After
4,472,261
% of Holdings
14.9%
Mirum Pharmaceuticals, Inc. (MIRM)
Howe Jolanda — SVP, GLOBAL CONTROLLER
Shares
1,840
Price
$105.29
Total Value
$193.73K
Shares Held After
1,274
% of Holdings
59.1%
Verastem, Inc. (VSTM)
Paterson Dan — Director
Shares
1,302
Price
$5.81
Total Value
$7.56K
Shares Held After
589,940
% of Holdings
0.2%
Vericel Corp (VCEL)
Halpin Michael — Chief Operating Officer
Shares
10,000
Price
$46.84
Total Value
$468.40K
Shares Held After
16,394
% of Holdings
37.9%
Fortrea Holdings Inc. (FTRE)
SANDERS MACHELLE — Director
Shares
9,700
Price
$18.01
Total Value
$174.70K
Shares Held After
36,399
% of Holdings
21.0%
Imunon, Inc. (IMNN)
Eylward Susan — General Counsel and Corp Sec
Shares
2,541
Price
$1.57
Total Value
$3.98K
Shares Held After
2,896
% of Holdings
46.7%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
22,082
Price
$12.54
Total Value
$276.91K
Shares Held After
202,380
% of Holdings
9.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
409
Price
$292.82
Total Value
$119.76K
Shares Held After
41,514
% of Holdings
1.0%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
991
Price
$291.71
Total Value
$289.09K
Shares Held After
41,923
% of Holdings
2.3%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
200
Price
$290.60
Total Value
$58.12K
Shares Held After
42,914
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
503
Price
$289.80
Total Value
$145.77K
Shares Held After
43,114
% of Holdings
1.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
356
Price
$288.75
Total Value
$102.79K
Shares Held After
43,617
% of Holdings
0.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
1,214
Price
$287.77
Total Value
$349.36K
Shares Held After
43,973
% of Holdings
2.7%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
1,032
Price
$286.80
Total Value
$295.97K
Shares Held After
45,187
% of Holdings
2.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
157
Price
$285.74
Total Value
$44.86K
Shares Held After
46,219
% of Holdings
0.3%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
33
Price
$284.55
Total Value
$9.39K
Shares Held After
46,376
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
105
Price
$284.14
Total Value
$29.83K
Shares Held After
46,409
% of Holdings
0.2%
Xeris Biopharma Holdings, Inc. (XERS)
McCulloch Kevin — President and Chief Operating Officer
Shares
15,000
Price
$8.02
Total Value
$120.24K
Shares Held After
1,676,126
% of Holdings
0.9%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,666
Price
$8.01
Total Value
$133.55K
Shares Held After
1,144,462
% of Holdings
1.4%
Orchestra BioMed Holdings, Inc. (OBIO)
Sherman Darren — Director
Shares
15,000
Price
$4.09
Total Value
$61.35K
Shares Held After
1,154,327
% of Holdings
1.3%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
12,415
Price
$10.05
Total Value
$124.72K
Shares Held After
871,737
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$518.61
Total Value
$165.96K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,220
Price
$517.49
Total Value
$631.33K
Shares Held After
324,763
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,075
Price
$516.49
Total Value
$1.07M
Shares Held After
325,983
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
4,218
Price
$515.73
Total Value
$2.18M
Shares Held After
328,058
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,667
Price
$514.83
Total Value
$858.23K
Shares Held After
332,276
% of Holdings
0.5%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
6,055
Price
$120.43
Total Value
$729.20K
Shares Held After
61,441
% of Holdings
9.0%
FENNEC PHARMACEUTICALS INC. (FENC)
Raykov Rosty — Former Director
Shares
10,000
Price
$9.58
Total Value
$95.80K
Shares Held After
131,633
% of Holdings
7.1%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
4,696
Price
$24.92
Total Value
$117.02K
Shares Held After
96,295
% of Holdings
4.6%
Ultragenyx Pharmaceutical Inc. (RARE)
Parschauer Karah Herdman — EVP and Chief Legal Officer
Shares
1,900
Price
$24.92
Total Value
$47.35K
Shares Held After
92,562
% of Holdings
2.0%
Alkermes plc. (ALKS)
snyderman nancy lynn MD — Director
Shares
44,472
Price
$50.35
Total Value
$2.24M
Shares Held After
15,395
% of Holdings
74.3%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$48.58
Total Value
$98.81K
Shares Held After
225,456
% of Holdings
0.9%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
9,000
Price
$48.58
Total Value
$437.22K
Shares Held After
69,389
% of Holdings
11.5%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
33,772
Price
$6.50
Total Value
$219.52K
Shares Held After
497,751
% of Holdings
6.4%
Contineum Therapeutics, Inc. (CTNM)
Stengone Carmine N. — Director
Shares
2,500
Price
$16.01
Total Value
$40.03K
Shares Held After
17,217
% of Holdings
12.7%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
16,589
Price
$23.05
Total Value
$382.36K
Shares Held After
9,110
% of Holdings
64.6%
Showing 1–50 of 183 transactions (page 1 of 4)